Skip to content

Study on the Influence of Dog - days Moxibustion on Human Immune Function

Study on the Influence of Dog - days Moxibustion on Human Immune Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018390
Enrollment
Unknown
Registered
2018-09-14
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased immune function

Interventions

Group 1:Dog days moxibustion therapy
Group 2:Placebo application therapy

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) good health male and female; 2) In 2018, there was no treatment with moxibustion; 3) Voluntarily join the study.

Exclusion criteria

Exclusion criteria: 1) Diseases of severe heart, brain, lung, liver, kidney and other organs, immune and blood system diseases, diabetes, thyroid dysfunction, gouty arthritis, malignant tumors, HIV infection, tuberculosis, etc. Infirm, pregnant women; 2) There are major infectious diseases in the past month, antibiotics are used by antibiotics, or there are infections and fevers; 3) There is a history of major mental illness, alcoholism, drug abuse and the use of immunomodulatory drugs in the past six months; 4) Serious allergies or previous allergies to moxibustion drugs, tapes, ulcers on the skin, fear of moxibustion.

Design outcomes

Primary

MeasureTime frame
Function of T cells;Function of B cells;Function of NK cells;

Contacts

Public ContactHong Wang

the First Affiliated Hospital of Jinan University

daxiaobaotwins@126.com+86 18903078566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026